To explore the molecular mechanism by which EMP1 modulates triple-negative breast cancer (TNBC) progression, we probed the PI3K/AKT pathway—a key regulator of TNBC pathogenesis. The gene discussed is EMP1; the disease is triple-negative breast carcinoma.